Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
On Nov. 6, 2025, Novo Nordisk announced it has agreed with the U.S. Administration to lower drug prices…
On Nov. 6, 2025, Novo Nordisk announced it has agreed with the U.S. Administration to lower drug prices…
On Nov. 27, 2020, the U.S. Department of Agriculture (USDA) announced that it had confirmed cases of SARS-CoV-2…
On Dec. 23, 2014, the U.S. Food and Drug Administration (FDA) approved a formulation of Novo Nordisk’s diabetes drug, liraglutide,…